ARCT-2304

N/A

Report date: 2026/05/12 15:11:36

Base Information

Drug NameARCT-2304

Drug Alias NameSelf-Amplifying mRNA pandemic Influenza vaccineARCT-2304LUNAR-H5N1LUNAR-FLU

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesArcturus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsInfluenza A virus infectionsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A